Vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, promotes regression of fibrotic plaques in a rat model of Peyronie’s disease

Kang Moon Song, Doo Yong Chung, Min Ji Choi, Kalyan Ghatak, Nguyen Nhat Minh, Anita Limanjaya, Mi Hye Kwon, Jiyeon Ock, Guo Nan Yin, Dae Kee Kim, Ji Kan Ryu, Jun Kyu Suh

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, promotes regression of fibrotic plaques in a rat model of Peyronie’s disease'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences